Baxano Surgical Secures $22M Financing to Grow Minimally Invasive Technology

Raleigh, N.C.-based Baxano Surgical secured $22 million in financing to provide the company with the flexibility and resources to grow its minimally invasive spine device segment.

Advertisement

The company obtained a credit facility of $15 million from Hercules. It will mature in 38 to 41 months. Baxano also entered into a $7 million common stock purchase agreement with Lincoln Park.

Baxano Surgical’s spine technology focuses on treating degenerative conditions of the lumbar spine.

More Articles on Devices:
Mazor Robotics Fills Renaissance Order From Singapore Distribution Parner
Smith & Nephew Acquires Brazilian Wound Care Company
Amedica Pens Manufacturing Deal with Kyocera Ceramics for Spine Devices

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.